|
Video: What is a Stock Split?
|
|
Argos Therapeutics is an immuno-oncology company focused on the development and commercialization of individualized immunotherapies for the treatment of cancer based on Co.'s proprietary precision immunotherapy technology platform called Arcelis. Co.'s proprietary Arcelis precision immunotherapy technology platform utilizes biological components from a patient's own cancer cells or virus to generate individualized immunotherapies. Co.'s primary product candidate is rocapuldencel-T, which is for the treatment of metastatic renal cell carcinoma and other cancers. Co. is also developing AGS-004, for the treatment of Human Immunodeficiency Virus. According to our ARGS split history records, ARGS has had 1 split. | |
|
ARGS (ARGS) has 1 split in our ARGS split history database. The split for ARGS took place on January 19, 2018. This was a 1 for 20 reverse split, meaning for each 20 shares of ARGS owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 50 share position following the split.
When a company such as ARGS conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the ARGS split history from start to finish, an original position size of 1000 shares would have turned into 50 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into ARGS shares, starting with a $10,000 purchase of ARGS, presented on a split-history-adjusted basis factoring in the complete ARGS split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
10/10/2014 |
|
End date: |
12/04/2018 |
|
Start price/share: |
$174.60 |
|
End price/share: |
$0.10 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.94% |
|
Average Annual Total Return: |
-83.43% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$5.72 |
|
Years: |
4.15 |
|
|
|
Date |
Ratio |
01/19/2018 | 1 for 20 |
|
|